| Technological Intervention for Reducing Alcohol Use Among People Living With HIV/AIDS (NCT03746600) | Carolyn Lauckner | 2020-05-23 |
| HIV Indicator Diseases in Hospital and Primary Care (NCT05225493) | Erasmus Medical Center | 2020-01-01 |
| Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea (NCT04192487) | Napo Pharmaceuticals, Inc. | 2019-10-22 |
| A Unified Intervention for Young Gay and Bisexual Men's Minority Stress, Mental Health, and HIV Risk (NCT02929069) | Yale University | 2016-09-01 |
| Clinical Trial of Recombinant Adenovirus Type 5 AIDS Vaccine (NCT02762045) | Centers for Disease Control and Prevention, China | 2016-04-01 |
| Community Intervention for HIV Testing & Care Linkage Among Young MSM in Bulgaria (NCT02639754) | Medical College of Wisconsin | 2015-12-01 |
| Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus (NCT02479698) | M.D. Anderson Cancer Center | 2015-07-23 |
| Accuracy Evaluation of the BD FACS Presto System (NCT02396355) | Becton, Dickinson and Company | 2015-02-01 |
| Adherence & Health Outcome Differences Amongst HIV Infected Patients Prescribed HAART (NCT02322827) | Olayemi Osiyemi MD | 2014-11-01 |
| Bioequivalence Study of Two Formulations With the Association of Tenofovir 300 mg and Emtricitabine 200 mg. (NCT02583464) | Laboratorio Elea Phoenix S.A. | 2014-09-01 |
| Peripheral Arterial Insufficiency Associated With HIV/AIDS (NCT02264509) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2014-09-01 |
| HIV Medication Adherence in Underserved Populations (NCT02392884) | Cedars-Sinai Medical Center | 2014-09-01 |
| DVD-based HIV/HCV Prevention Intervention for Drug-Involved Latino Criminal Justice Clients (NCT02116179) | University of Delaware | 2014-07-01 |
| HIV, Buprenorphine, and the Criminal Justice System (STRIDE2) (NCT03583138) | Yale University | 2014-06-23 |
| Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer (NCT01590017) | AIDS Malignancy Consortium | 2014-04-01 |
| Anti-HIV False Positivity Rate in Pregnant Women; and Investigating the Factors Affecting This Situation (NCT03777371) | Kanuni Sultan Suleyman Training and Research Hospital | 2014-01-01 |
| Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults (NCT01967940) | Gilead Sciences | 2013-10-25 |
| Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults (NCT01968551) | Gilead Sciences | 2013-09-03 |
| Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in Uganda (NCT01916759) | Emory University | 2013-06-01 |
| Safety and Immunogenicity of Recombinant HIV Vaccines for HIV/AIDS (NCT01881581) | Centers for Disease Control and Prevention, China | 2013-06-01 |
| Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients (NCT01671501) | University of California, San Francisco | 2013-03-01 |
| Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB (NCT02348177) | Drugs for Neglected Diseases | 2013-01-01 |
| Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents (NCT01721109) | Gilead Sciences | 2012-12-06 |
| Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women (NCT01705574) | Gilead Sciences | 2012-10-24 |
| Pilot Study of Immediate HIV Treatment in Guangxi, China (NCT01892228) | National Center for AIDS/STD Control and Prevention, China CDC | 2012-07-01 |
| D/C/F/TAF Versus COBI-boosted DRV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment Naive Adults (NCT01565850) | Gilead Sciences | 2012-04-01 |
| Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIV (NCT01433185) | University of Washington | 2012-04-01 |
| HIV, Buprenorphine, and the Criminal Justice System (NCT01550341) | Yale University | 2012-02-23 |
| Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya (NCT01425073) | University of Washington | 2012-02-01 |
| Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients (NCT01533259) | Gilead Sciences | 2012-01-01 |
| Dimiracetam in Painful Neuropathies Affecting AIDS Patients (NCT01444690) | Neurotune AG | 2012-01-01 |
| Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults (NCT01497899) | Gilead Sciences | 2011-12-28 |
| Study to Evaluate Switching From Regimens Consisting of a Nonnucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients (NCT01495702) | Gilead Sciences | 2011-12-01 |
| Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients (NCT01475838) | Gilead Sciences | 2011-11-01 |
| A Commitment Device for Medication Adherence Among HIV Patients (NCT01455740) | National Bureau of Economic Research, Inc. | 2011-10-01 |
| Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults (NCT01440569) | Gilead Sciences | 2011-09-01 |
| Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment (NCT01363011) | Gilead Sciences | 2011-05-01 |
| Managerial Database II (NCT01322217) | University of North Carolina, Chapel Hill | 2011-04-01 |
| Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru (NCT02630082) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-04-01 |
| Text Messaging to Improve Adherence to Clinic Visits and Reduce Early Resumption of Sexual Intercourse After Male Circumcision (NCT01186575) | University of Washington | 2010-08-01 |
| Intervention for HIV-Positive Black Young Men Who Have Sex With Men (YMSM) (NCT01502618) | University of North Carolina, Chapel Hill | 2010-08-01 |
| HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence (NCT01369056) | University of Tartu | 2010-07-01 |
| Mesalamine to Reduce T Cell Activation in HIV Infection (NCT01090102) | University of California, San Francisco | 2010-06-01 |
| Chinese Network of Pediatric Antiretroviral Therapy (NCT01210924) | National Center for AIDS/STD Control and Prevention, China CDC | 2010-04-01 |
| Computerized HIV/Sexually Transmitted Disease (STD) Prevention Program (NCT00947947) | University of North Carolina, Chapel Hill | 2010-02-01 |
| Clinic-based ART Diagnostic Evaluation (NCT01791556) | Walter Reed Army Institute of Research (WRAIR) | 2010-01-26 |
| Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia (NCT02396979) | Yale University | 2010-01-01 |
| Medications for Chronic HIV: Education and Collaboration (NCT01038076) | Boston University | 2009-12-01 |
| Pilot Assessment of Lopinavir/Ritonavir and Maraviroc (NCT00981318) | Rodwick, Barry M., M.D. | 2009-12-01 |
| An Expanded Safety Study of Dapivirine Gel 4759 in Africa (NCT00917891) | International Partnership for Microbicides, Inc. | 2009-11-01 |
| HIV Prevention and Care of Psychological Trauma in Vulnerable Rwandan Youth (NCT01401335) | Stanford University | 2009-10-01 |
| Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses. (NCT00985543) | Kirby Institute | 2009-10-01 |
| TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients (NCT00896051) | Janssen R&D Ireland | 2009-08-01 |
| An Expanded Safety Study of Dapivirine Gel 4789 in Africa (NCT00917904) | International Partnership for Microbicides, Inc. | 2009-07-01 |
| A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients (NCT00903682) | Janssen-Cilag International NV | 2009-06-01 |
| Safety of Cotrimoxazole in HIV- and HAART-exposed Infants (NCT01086878) | Harvard School of Public Health (HSPH) | 2009-02-01 |
| Evaluating an Exercise Program to Reduce Cardiovascular Risk Factors in Children Infected With HIV (NCT00908284) | University of Miami | 2008-12-01 |
| Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT) (NCT01230580) | Medical Research Council | 2008-11-01 |
| Spatial Epidemiology of HIV Infection (NCT01377272) | National Taiwan University Hospital | 2008-10-01 |
| Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for Tuberculosis (NCT01315301) | Karolinska Institutet | 2008-08-01 |
| Anatomic and Visual Function Assessments on Asymptomatic HIV-positive Patients (NCT00871078) | Federal University of São Paulo | 2008-06-01 |
| Efficacy of HIV Post-Test Support for ANC in South Africa (NCT01683461) | University of North Carolina, Chapel Hill | 2008-05-01 |
| Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED) (NCT00551330) | Merck Sharp & Dohme LLC | 2007-09-01 |
| Multicenter, Safety Study Of Maraviroc (NCT00478231) | ViiV Healthcare | 2007-07-01 |
| Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5) (NCT00523211) | Merck Sharp & Dohme LLC | 2007-07-01 |
| Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED) (NCT00474370) | Merck Sharp & Dohme LLC | 2007-05-15 |
| Relationship of Viral Resistance Development to CD4 Monitoring Alone or With Viral Load Monitoring (NCT00434070) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-02-07 |
| Decision-Making of Hispanics and African-Americans With HIV/AIDS Participating in Clinical Trials (NCT00394004) | National Institutes of Health Clinical Center (CC) | 2006-10-26 |
| Examining the Link Between Heart Disease and HIV Infection in Women (NCT00312468) | Albert Einstein College of Medicine | 2006-10-01 |
| A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent. (NCT00381212) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2006-09-01 |
| Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis (NCT00698334) | All India Institute of Medical Sciences | 2006-04-01 |
| Computer Assisted Rx Education for HIV-Positives: CARE+ (NCT00443378) | University of Washington | 2006-03-01 |
| The Efficacy of the HIV/AIDS Symptom Management Manual (NCT00241202) | University of California, San Francisco | 2005-10-01 |
| Vicriviroc, a CCR5 Inhibitor, Added to an Optimized Antiretroviral Therapy for Previously Treated HIV (VICTOR-E2) (Study P04285 (NCT00243568) | Merck Sharp & Dohme LLC | 2005-09-01 |
| HIV Prevention Intervention for Couples (NCT00325585) | National Development and Research Institutes, Inc. | 2005-04-01 |
| Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED) (NCT00105157) | Merck Sharp & Dohme LLC | 2005-03-01 |
| Effectiveness of Structured Ecosystems Therapy for Reducing HIV Risk Behaviors and Improving Treatment Adherence in HIV Infected Men Released From Prison (NCT00344591) | University of California, San Francisco | 2005-01-01 |
| A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED) (NCT00100048) | Merck Sharp & Dohme LLC | 2005-01-01 |
| Effectiveness of Enhanced Counseling and Observed Therapy on Antiretroviral Adherence in People With HIV (NCT00602758) | University of Missouri, Kansas City | 2004-12-01 |
| PI Vs. NNRTI Based Therapy for HIV Advanced Disease (NCT00162643) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2004-12-01 |
| Longitudinal Study of HAART, Social Networks, & Adherence (NCT00272220) | University of Washington | 2004-10-01 |
| Retrovirus Epidemiology Donor Study-II (REDS-II) (NCT00097006) | National Heart, Lung, and Blood Institute (NHLBI) | 2004-09-01 |
| Efficacy of Elevated CD4 Counts on CMV Retinitis (NCT00091884) | National Eye Institute (NEI) | 2004-07-01 |
| Proton Magnetic Resonance Spectroscopy (1H MRS) in Evaluating the Bone Marrow, Muscle and Adipose Tissue on Normal and Human Immunodeficiency Virus Infected Subjects (NCT00172315) | National Taiwan University Hospital | 2003-12-01 |
| Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIV (NCT00144157) | Boehringer Ingelheim | 2003-06-01 |
| Clinical and Therapeutic Evaluation of the Infection by HIV/AIDS (NCT02191215) | Boehringer Ingelheim | 2003-06-01 |
| Analysis of Immune Responses to HIV Vaccines (NCT00068978) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-04-01 |
| A Study of Single Dose Nevirapine (NVP) Combined With Combivir® for the Prevention of Mother to Child Transmission (pMTCT) - Treatment Options Preservation Study (TOPS) (NCT00144183) | Boehringer Ingelheim | 2003-01-01 |
| Treatment of Depression With Massage in HIV (NCT00033852) | National Center for Complementary and Integrative Health (NCCIH) | 2002-04-01 |
| Pharmacokinetic Study of Interaction Between Nevirapine and Methadone in HIV-1 Infected, Opioid-dependent Adults (NCT00273988) | Boehringer Ingelheim | 2002-04-01 |
| Multidisciplinary Inpatient Palliative Care Intervention (NCT00325611) | Kaiser Permanente | 2002-04-01 |
| The Use of Reiki for Patients With Advanced AIDS (NCT00032721) | National Center for Complementary and Integrative Health (NCCIH) | 2002-03-01 |
| Immune Restoration by Lipoic Acid in AIDS (NCT00033176) | National Center for Complementary and Integrative Health (NCCIH) | 2002-02-01 |
| Once-Daily Drug Regimen for HIV-Infected Patients (NCT00001968) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-01-01 |
| KSHV Infection in Blood Donors From Texas (NCT00006310) | The University of Texas Health Science Center at San Antonio | 1999-04-01 |
| CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes (NCT00966160) | University of Cologne | 1999-01-01 |
| Longitudinal Study of Ocular Complications of AIDS (LSOCA) (NCT00000168) | Johns Hopkins Bloomberg School of Public Health | 1998-08-01 |
| A Pilot Study of Adherence to Oral Medication and Health Beliefs of Adolescents With HIV and Their Mothers (NCT00001699) | National Cancer Institute (NCI) | 1998-06-01 |
| Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected Patients (NCT00001650) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-09-19 |
| Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis (NCT00001646) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-08-01 |